Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma
- 1 February 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 35 (2) , 159-168
Abstract
Glioblastoma (GBM) is the most common primary brain cancer in adults and is virtually incurable. Recent studies have shown that cytomegalovirus (CMV) is present in majority of GBMs. To evaluate whether the CMV antigens pp65 and IE1, which are expressed in GBMs, could be targeted by CMV-specific T cells, we measured the frequency of T cells targeting pp65 and IE1 in the peripheral blood of a cohort of 11 sequentially diagnosed CMV-seropositive GBM patients, and evaluated whether it was feasible to expand autologous CMV-specific T cells for future clinical studies. All 11 CMV-seropositive GBM patients had T cells specific for pp65 and IE1 in their peripheral blood assessed by IFNγ enzyme-linked immunospot assay. However, the precursor frequency of pp65-specific T cells was decreased in comparison with healthy donors (P=0.001). We successfully reactivated and expanded CMV-specific T cells from 6 out of 6 GBM patients using antigen-presenting cells transduced with an adenoviral vector encoding pp65 and IE1. CMV-specific T-cell lines contained CD4+ as well as CD8+ T cells, recognized pp65+ and IE1+ targets and killed CMV-infected autologous GBM cells. Infusion of such CMV-specific T-cell lines may extend the benefits of T-cell therapy to patients with CMV+ GBMs.Keywords
This publication has 38 references indexed in Scilit:
- Mechanisms of Immunomodulation in Human GlioblastomaImmunotherapy, 2011
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell ImmunotherapyClinical Cancer Research, 2011
- Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal CarcinomaJournal of Immunotherapy, 2010
- Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasoneNeuro-Oncology, 2010
- Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive ImmunotherapyJournal of Immunotherapy, 2008
- Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cellsBlood, 2006
- Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patientsBlood, 2006
- Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's DiseaseJournal of Experimental Medicine, 2004
- Adoptive immunotherapy with allogeneic Epstein–Barr virus (EBV)‐specific cytotoxic T‐lymphocytes for recurrent, EBV‐positive Hodgkin diseaseCancer, 2004
- Brain TumorsNew England Journal of Medicine, 2001